JenniferLynnDriverMD

PubMed

• 45 citations
  Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells
  Elizabeth C. Martin, Steven Elliott, Lyndsay V. Rhodes, James W. Antoon, Claire Fewell, Yun Zhu, Jennifer L. Driver, Mona Jodari-Karimi, Christopher W. Taylor, Erik K....> ;Molecular Carcinogenesis. 2014 Jan 1
• 25 citations
  Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer:
  James W. Antoon, Martin D. White, Jennifer L. Driver, Matthew E. Burow, Barbara S. Beckman> ;Experimental Biology and Medicine. 2012 Jul 1
• 190 citations
  Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
  Chandra R. Tate, Lyndsay V. Rhodes, H. Chris Segar, Jennifer L. Driver, F. Nell Pounder, Matthew E. Burow, Bridgette M. Collins-Burow> ;Breast Cancer Research. 2012 May 21
• 55 citations
  The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.
  Lyndsay V. Rhodes, Ashley M. Nitschke, H. Chris Segar, Elizabeth C. Martin, Jennifer L. Driver, Steven Elliott, Seung Yoon Nam, Meng Li, Kenneth P. Nephew, Matthew E. ...> ;Oncology Reports. 2011 Oct 4
• 121 citations
  Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
  James W. Antoon, Martin D. White, Evelyn M. Slaughter, Jennifer L. Driver, Hafez S. Khalili, Steven Elliott, Charles D. Smith, Matthew E. Burow, Barbara S. Beckman> ;Cancer Biology & Therapy. 2011 Apr 1
• 33 citations
  Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.
  Quan Jiang, Florastina Payton-Stewart, Steven Elliott, Jennifer L. Driver, Lyndsay V. Rhodes, Qiang Zhang, Shilong Zheng, Deepak Bhatnagar, Stephen M. Boue, Bridgette ...> ;Journal of Medicinal Chemistry. 2010 Aug 26
• Join now to see all